JP6651466B2 - アナツバメ巣を原材料とする酵母発酵液、組成物及び素材の製造方法 - Google Patents
アナツバメ巣を原材料とする酵母発酵液、組成物及び素材の製造方法 Download PDFInfo
- Publication number
- JP6651466B2 JP6651466B2 JP2016572943A JP2016572943A JP6651466B2 JP 6651466 B2 JP6651466 B2 JP 6651466B2 JP 2016572943 A JP2016572943 A JP 2016572943A JP 2016572943 A JP2016572943 A JP 2016572943A JP 6651466 B2 JP6651466 B2 JP 6651466B2
- Authority
- JP
- Japan
- Prior art keywords
- yeast
- fermentation
- raw material
- nest
- swallow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002994 raw material Substances 0.000 title claims description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims 16
- 239000002131 composite material Substances 0.000 title 1
- 239000011344 liquid material Substances 0.000 title 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 45
- 238000000855 fermentation Methods 0.000 claims description 39
- 230000004151 fermentation Effects 0.000 claims description 39
- 239000000463 material Substances 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 28
- 241000167880 Hirundinidae Species 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 235000015872 dietary supplement Nutrition 0.000 claims description 16
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 13
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- 208000004296 neuralgia Diseases 0.000 claims description 10
- 208000021722 neuropathic pain Diseases 0.000 claims description 10
- 235000021067 refined food Nutrition 0.000 claims description 9
- 235000005770 birds nest Nutrition 0.000 claims description 8
- 235000005765 wild carrot Nutrition 0.000 claims description 8
- 244000000626 Daucus carota Species 0.000 claims description 7
- 208000004454 Hyperalgesia Diseases 0.000 claims description 7
- 206010053552 allodynia Diseases 0.000 claims description 7
- 235000014214 soft drink Nutrition 0.000 claims description 7
- 230000009385 viral infection Effects 0.000 claims description 4
- 241000235343 Saccharomycetales Species 0.000 claims 2
- 244000286779 Hansenula anomala Species 0.000 description 31
- 239000000047 product Substances 0.000 description 22
- 235000013305 food Nutrition 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 11
- 241000255927 Papilio polyxenes Species 0.000 description 10
- 241000235070 Saccharomyces Species 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000023589 ischemic disease Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229930014626 natural product Natural products 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000397426 Centroberyx lineatus Species 0.000 description 4
- 240000007357 Nauclea orientalis Species 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000004099 anaerobic respiration Effects 0.000 description 3
- 230000003574 anti-allodynic effect Effects 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 241000429775 Acraea rogersi Species 0.000 description 2
- 241001578852 Aegla franca Species 0.000 description 2
- 241000203244 Aerodramus brevirostris Species 0.000 description 2
- 241000352200 Aerodramus hirundinaceus Species 0.000 description 2
- 241000011480 Aerodramus papuensis Species 0.000 description 2
- 241000203250 Aerodramus salangana Species 0.000 description 2
- 241000203248 Aerodramus sawtelli Species 0.000 description 2
- 241000203256 Aerodramus spodiopygius Species 0.000 description 2
- 241000999994 Aerodramus vanikorensis Species 0.000 description 2
- 241001225657 Aerodramus vulcanorum Species 0.000 description 2
- 241000999993 Aerodramus whiteheadi Species 0.000 description 2
- 241000062811 Apus unicolor Species 0.000 description 2
- 241000940786 Atherigona soccata Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 241001304241 Hirundo angolensis Species 0.000 description 2
- 241000034246 Leucophaeus Species 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- -1 penetrants Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000003079 salivary gland Anatomy 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 125000005629 sialic acid group Chemical group 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- 230000037373 wrinkle formation Effects 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000203186 Collocalia troglodytes Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 241000235646 Cyberlindnera jadinii Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000178951 Endomyces Species 0.000 description 1
- 235000014683 Hansenula anomala Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241001159781 Kazachstania spencerorum Species 0.000 description 1
- 241000039979 Kazachstania turicensis Species 0.000 description 1
- 241001123232 Kazachstania unispora Species 0.000 description 1
- 241000965982 Kazachstania zonata Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 244000285963 Kluyveromyces fragilis Species 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 241000937897 Meyerozyma caribbica Species 0.000 description 1
- 241001123224 Naumovozyma dairenensis Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 241000198071 Saccharomyces cariocanus Species 0.000 description 1
- 241000877399 Saccharomyces chevalieri Species 0.000 description 1
- 235000018370 Saccharomyces delbrueckii Nutrition 0.000 description 1
- 241000877401 Saccharomyces ellipsoideus Species 0.000 description 1
- 241001407717 Saccharomyces norbensis Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000582914 Saccharomyces uvarum Species 0.000 description 1
- 241000235003 Saccharomycopsis Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 241001278026 Starmerella bombicola Species 0.000 description 1
- 241000235006 Torulaspora Species 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 241000684582 Torulaspora microellipsoides Species 0.000 description 1
- 241001504501 Troglodytes Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 241000235017 Zygosaccharomyces Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 241000192248 [Candida] saitoana Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960002181 saccharomyces boulardii Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Claims (12)
- アマツバメ科アナツバメ属に属する鳥の巣の酵母発酵液であって、
発酵により得られたN−アセチルノイラミン酸の含有率が酵母発酵液中7%以上であり、
発酵に用いる酵母が出芽酵母(Saccharomyces cerevisiae)であるもの。 - 医薬品、医薬部外品、健康補助用食品、栄養補助用食品、加工食品及び清涼飲料水のいずれかとしての使用のための、
請求項1に記載の酵母発酵液。 - 前記巣、前記酵母及び水のみで発酵を行うことで得られる、
請求項1又は2に記載の酵母発酵液。 - 請求項1に記載の酵母発酵液を含有する組成物。
- 医薬品、医薬部外品、健康補助用食品、栄養補助用食品、加工食品及び清涼飲料水のいずれかである、
請求項4に記載の組成物。 - アロディニア又は神経因性疼痛を改善するための、
請求項4に記載の組成物。 - ウイルス感染を防ぐための、
請求項4に記載の組成物。 - 前記酵母発酵液は、前記巣、前記酵母及び水のみで発酵を行うことで得られる、
請求項4−7のいずれかに記載の組成物。 - アマツバメ科アナツバメ属に属する鳥の巣を原料とし、
前記原料に水分及び酵母を添加し、ここで前記酵母を出芽酵母(Saccharomyces cerevisiae)とし、さらに質量比を前記原料100gに対して前記水分を50g〜200gとし、
前記原料を前記水分とともに前記酵母で発酵させる、
素材製造方法。 - 発酵は密閉状態で行う、
請求項9に記載の素材製造方法。 - 発酵後、前記水分の少なくとも一部を蒸発させる、
請求項10に記載の素材製造方法。 - 前記発酵は前記原料、水及び前記酵母のみで行われる、
請求項9−11のいずれかに記載の素材製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015031065 | 2015-02-03 | ||
JP2015031065 | 2015-02-03 | ||
PCT/JP2015/003205 WO2016125208A1 (ja) | 2015-02-03 | 2015-06-25 | アナツバメ巣を原材料とする素材、組成物及び素材の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2016125208A1 JPWO2016125208A1 (ja) | 2017-11-16 |
JP6651466B2 true JP6651466B2 (ja) | 2020-02-19 |
Family
ID=56563575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016572943A Active JP6651466B2 (ja) | 2015-02-03 | 2015-06-25 | アナツバメ巣を原材料とする酵母発酵液、組成物及び素材の製造方法 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6651466B2 (ja) |
CN (1) | CN107405365B (ja) |
SG (1) | SG11201705801VA (ja) |
WO (1) | WO2016125208A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112931862A (zh) * | 2021-03-15 | 2021-06-11 | 北京市小仙炖电子商务有限公司 | 一种冰糖燕窝及其制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0242962A (ja) * | 1988-08-04 | 1990-02-13 | Susumu Murofushi | 機能性食品の製造方法 |
JPH05214003A (ja) * | 1992-02-04 | 1993-08-24 | Mect Corp | 好中球遊走阻止薬 |
JP4666733B2 (ja) * | 2000-08-23 | 2011-04-06 | コンビ株式会社 | ウイルス感染抑制剤 |
JP4976629B2 (ja) * | 2001-09-27 | 2012-07-18 | コンビ株式会社 | 美肌促進剤 |
JP2003259835A (ja) * | 2001-12-28 | 2003-09-16 | Oubiken:Kk | 発酵製品の製造とその利用 |
JP4401659B2 (ja) * | 2002-02-04 | 2010-01-20 | 協和発酵バイオ株式会社 | インスリン分泌促進剤 |
JP3984953B2 (ja) * | 2003-12-26 | 2007-10-03 | 堯 近藤 | 健康食品の製造方法 |
JP4156507B2 (ja) * | 2003-12-26 | 2008-09-24 | 堯 近藤 | 豚のプラセンタを含有した健康食品の製造方法 |
JP2007061058A (ja) * | 2005-09-02 | 2007-03-15 | Hideo Yamamoto | 糖鎖栄養素を含む免疫強化食品及びその製造方法 |
JP4005115B1 (ja) * | 2007-02-08 | 2007-11-07 | 日本臓器製薬株式会社 | 疼痛疾患治療剤 |
US20100143535A1 (en) * | 2007-07-12 | 2010-06-10 | Hidemasa Motoshima | Method for producing composition containing sialic acid compound |
CN102334680B (zh) * | 2011-08-08 | 2012-12-19 | 邓毛程 | 一种红曲燕窝及其制备方法 |
CN102362637B (zh) * | 2011-09-30 | 2013-03-13 | 邓毛程 | 利用微生物活菌悬液和/或粗酶液去除燕窝中亚硝酸盐的方法与应用 |
JP5914577B2 (ja) * | 2014-06-09 | 2016-05-11 | コンビ株式会社 | コラーゲン産生低下抑制剤、それを含む皮膚外用組成物および化粧料 |
CN104146885A (zh) * | 2014-07-14 | 2014-11-19 | 武汉中科光谷绿色生物技术有限公司 | N-乙酰神经氨酸水合物在育发产品中的应用 |
-
2015
- 2015-06-25 CN CN201580074756.3A patent/CN107405365B/zh active Active
- 2015-06-25 WO PCT/JP2015/003205 patent/WO2016125208A1/ja active Application Filing
- 2015-06-25 SG SG11201705801VA patent/SG11201705801VA/en unknown
- 2015-06-25 JP JP2016572943A patent/JP6651466B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CN107405365B (zh) | 2021-06-01 |
JPWO2016125208A1 (ja) | 2017-11-16 |
SG11201705801VA (en) | 2017-08-30 |
CN107405365A (zh) | 2017-11-28 |
WO2016125208A1 (ja) | 2016-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2931289B1 (fr) | Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses | |
JP2007535575A (ja) | 生物活性化合物およびその使用方法 | |
JPWO2009081833A1 (ja) | 安定化された(ss)−s−アデノシル−l−メチオニンを含有する微生物乾燥菌体又は微生物エキス、及びその製造方法 | |
JP5528629B2 (ja) | 酵母菌から抽出されたポリリン酸,ポリリン酸の塩又はポリリン酸の溶媒和物を含むポリリン酸組成物及びその製造方法。 | |
JP2018058903A (ja) | 成長ホルモン分泌促進剤 | |
US8962684B2 (en) | Antioxidant composition | |
JP6651466B2 (ja) | アナツバメ巣を原材料とする酵母発酵液、組成物及び素材の製造方法 | |
TW202033205A (zh) | 蝦紅素複方組合物及其調節血脂之應用 | |
EP0974349A1 (en) | Athletic endurance increasing agent | |
JP2009269832A (ja) | カルシトニン遺伝子関連ペプチド及びインスリン様成長因子−1の産生促進組成物 | |
EP2999467B1 (fr) | Utilisation d'une association de deux composés pour le traitement et/ou la prévention de troubles osseux | |
JP2023075284A (ja) | 経口組成物 | |
JP2017193497A (ja) | 筋肉増強剤 | |
WO2010027014A1 (ja) | S-アデノシル-l-メチオニンの吸収性を高める方法およびs-アデノシル-l-メチオニンの吸収性が高められた組成物 | |
JP7069531B2 (ja) | ピロロキノリンキノン又はその塩と分岐鎖アミノ酸とを含むカプセル | |
JP2022115770A (ja) | 低温発酵減圧抽出法 | |
JP7104193B2 (ja) | 筋肉増強剤 | |
KR102581570B1 (ko) | 신규 바실러스 벨레젠시스 균주를 포함하는 면역증강용 조성물 | |
JP2018172301A (ja) | 経口組成物 | |
JP2024100951A (ja) | アトロジン-1発現抑制剤 | |
CN104523736B (zh) | 一种防治心肌梗死的药物组合物及其应用 | |
CN118240722A (zh) | 一种副干酪乳酪杆菌及其防治牙周炎的应用 | |
JP6333933B1 (ja) | 絹糸腺発酵液 | |
HU190782B (en) | Process for producing pharmaceutical compositions for profilacting and treating negative changes of hygienics on epithelium | |
JP2020079309A (ja) | 筋肉増強剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170710 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180625 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190604 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190730 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190919 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191023 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6651466 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |